French CAR-T biotech Mnemo Ther­a­peu­tics shut­ters US op­er­a­tions

A Sofinno­va-backed CAR-T mak­er has shut down its New York and Prince­ton, NJ sites and will con­tin­ue op­er­at­ing out of its Paris hub.

Mnemo Ther­a­peu­tics turned the lights off at its US op­er­a­tions ef­fec­tive im­me­di­ate­ly on Feb. 23, ac­cord­ing to em­ploy­ees’ posts on LinkedIn and con­fir­ma­tion from co-founder and op­er­at­ing chief Alain Maiore.

“When Se­bas­t­ian [Amigore­na] and I start­ed Mnemo Tx, we were look­ing to build a com­pa­ny where the hu­man val­ue of ‘stand­ing shoul­der to shoul­der’ in dif­fi­cult time would typ­i­fy the DNA of our teams across the ocean,” Maiore wrote on LinkedIn in re­cent days. “The de­ci­sion we had to make about shut­ting down our US op­er­a­tions, to move back our CT ef­fort to Eu­rope, next to our tar­get dis­cov­ery plat­form was a very dif­fi­cult one.”

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER